Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) /ID# 149020

Rio de Janeiro 20231-050

0 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Multiple Myeloma

Studies at this site

• A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy — Completed